Evidence map›Paper›PMID 27606840›Full record

ArticlePLoS pathogens2016

The Structural Architecture of an Infectious Mammalian Prion Using Electron Cryomicroscopy.

Ester Vázquez-Fernández, Matthijn R Vos, Pavel Afanasyev, Lino Cebey, Alejandro M Sevillano, Enric Vidal, Isaac Rosa, Ludovic Renault, Adriana Ramos, Peter J Peters and 5 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Prion diseases: Lessons from historical outbreaks and potential emerging ones.Protein science : a publication of the Protein Society · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Post-translational modifications in prion diseases.Frontiers in molecular neuroscience · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Structural biology of ex vivo mammalian prions.The Journal of biological chemistry · 2022
    Review
  18. Review
  19. Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ester Vázquez-FernándezDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
Matthijn R VosFEI Company, Nanoport Europe, Eindhoven, The Netherlands.
Pavel AfanasyevInstitute of Biology Leiden, NeCEN, Leiden, The Netherlands.
Lino CebeyDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
Alejandro M SevillanoCIMUS Biomedical Research Institute University of Santiago de Compostela-IDIS, Santiago de Compostela, Spain.
Enric VidalIRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de la Universitat Autònoma de Barcelona, Bellaterra, Catalonia, Spain.
Isaac RosaCIMUS Biomedical Research Institute University of Santiago de Compostela-IDIS, Santiago de Compostela, Spain.
Ludovic RenaultDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
Adriana RamosCIMUS Biomedical Research Institute University of Santiago de Compostela-IDIS, Santiago de Compostela, Spain.
Peter J PetersThe Maastricht Multimodal Molecular Imaging Institute, Maastricht University, Maastricht, The Netherlands.
José Jesús FernándezCentro Nacional de Biotecnologia - CSIC, Campus Universidad Autónoma, Madrid, Spain.
Marin van HeelInstitute of Biology Leiden, NeCEN, Leiden, The Netherlands.
Howard S YoungDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
Jesús R RequenaCIMUS Biomedical Research Institute University of Santiago de Compostela-IDIS, Santiago de Compostela, Spain.
Holger WilleDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0001-5102-8706

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The structure of the infectious prion protein (PrPSc), which is responsible for Creutzfeldt-Jakob disease in humans and bovine spongiform encephalopathy, has escaped all attempts at elucidation due to its insolubility and propensity to aggregate. PrPSc replicates by converting the non-infectious, cellular prion protein (PrPC) into the misfolded, infectious conformer through an unknown mechanism. PrPSc and its N-terminally truncated variant, PrP 27-30, aggregate into amorphous aggregates, 2D crystals, and amyloid fibrils. The structure of these infectious conformers is essential to understanding prion replication and the development of structure-based therapeutic interventions. Here we used the repetitive organization inherent to GPI-anchorless PrP 27-30 amyloid fibrils to analyze their structure via electron cryomicroscopy. Fourier-transform analyses of averaged fibril segments indicate a repeating unit of 19.1 Å. 3D reconstructions of these fibrils revealed two distinct protofilaments, and, together with a molecular volume of 18,990 Å3, predicted the height of each PrP 27-30 molecule as ~17.7 Å. Together, the data indicate a four-rung β-solenoid structure as a key feature for the architecture of infectious mammalian prions. Furthermore, they allow to formulate a molecular mechanism for the replication of prions. Knowledge of the prion structure will provide important insights into the self-propagation mechanisms of protein misfolding.

Indexed as

AmyloidAnimalsCattleCreutzfeldt-Jakob SyndromeCryoelectron MicroscopyEncephalopathy, Bovine SpongiformHumansPrPC ProteinsPrPSc ProteinsAmyloidPrPC ProteinsPrPSc Proteins

Identifiers

PMID27606840
PMCPMC5015997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.